nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—CYP2B6—Thiotepa—urinary bladder cancer	0.1	0.132	CbGbCtD
Erythromycin—SLC22A7—Fluorouracil—urinary bladder cancer	0.088	0.116	CbGbCtD
Erythromycin—ABCC1—Epirubicin—urinary bladder cancer	0.074	0.0973	CbGbCtD
Erythromycin—ABCB1—Mitomycin—urinary bladder cancer	0.0677	0.089	CbGbCtD
Erythromycin—ABCC1—Etoposide—urinary bladder cancer	0.0577	0.0758	CbGbCtD
Erythromycin—SLC22A7—Methotrexate—urinary bladder cancer	0.0485	0.0638	CbGbCtD
Erythromycin—ABCC1—Doxorubicin—urinary bladder cancer	0.0393	0.0517	CbGbCtD
Erythromycin—ABCC1—Methotrexate—urinary bladder cancer	0.0381	0.0501	CbGbCtD
Erythromycin—SLCO1A2—Methotrexate—urinary bladder cancer	0.034	0.0447	CbGbCtD
Erythromycin—CYP3A4—Thiotepa—urinary bladder cancer	0.0308	0.0404	CbGbCtD
Erythromycin—CYP2B6—Cisplatin—urinary bladder cancer	0.0276	0.0363	CbGbCtD
Erythromycin—CYP3A5—Etoposide—urinary bladder cancer	0.0214	0.0281	CbGbCtD
Erythromycin—ABCB1—Gemcitabine—urinary bladder cancer	0.0195	0.0256	CbGbCtD
Erythromycin—CYP1A2—Fluorouracil—urinary bladder cancer	0.0191	0.0251	CbGbCtD
Erythromycin—CYP2B6—Doxorubicin—urinary bladder cancer	0.0185	0.0243	CbGbCtD
Erythromycin—CYP1A2—Etoposide—urinary bladder cancer	0.0159	0.0209	CbGbCtD
Erythromycin—ABCB1—Cisplatin—urinary bladder cancer	0.0142	0.0186	CbGbCtD
Erythromycin—ABCB1—Etoposide—urinary bladder cancer	0.0139	0.0183	CbGbCtD
Erythromycin—MLNR—smooth muscle tissue—urinary bladder cancer	0.0114	0.354	CbGeAlD
Erythromycin—ABCB1—Doxorubicin—urinary bladder cancer	0.00949	0.0125	CbGbCtD
Erythromycin—ABCB1—Methotrexate—urinary bladder cancer	0.0092	0.0121	CbGbCtD
Erythromycin—CYP3A4—Etoposide—urinary bladder cancer	0.00834	0.011	CbGbCtD
Erythromycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00569	0.00747	CbGbCtD
Erythromycin—CYP1A2—urine—urinary bladder cancer	0.00293	0.091	CbGeAlD
Erythromycin—CYP3A4—urine—urinary bladder cancer	0.00212	0.0658	CbGeAlD
Erythromycin—SLC22A7—renal system—urinary bladder cancer	0.00181	0.0562	CbGeAlD
Erythromycin—ABCC1—prostate gland—urinary bladder cancer	0.00132	0.041	CbGeAlD
Erythromycin—Skin exfoliation—Thiotepa—urinary bladder cancer	0.00113	0.009	CcSEcCtD
Erythromycin—Tenderness—Fluorouracil—urinary bladder cancer	0.00113	0.00894	CcSEcCtD
Erythromycin—ABCC1—seminal vesicle—urinary bladder cancer	0.00112	0.0347	CbGeAlD
Erythromycin—Hepatotoxicity—Etoposide—urinary bladder cancer	0.00111	0.00877	CcSEcCtD
Erythromycin—SLCO1A2—renal system—urinary bladder cancer	0.0011	0.034	CbGeAlD
Erythromycin—Tenderness—Cisplatin—urinary bladder cancer	0.00107	0.00848	CcSEcCtD
Erythromycin—Hearing impaired—Gemcitabine—urinary bladder cancer	0.00105	0.00833	CcSEcCtD
Erythromycin—Erythema—Mitomycin—urinary bladder cancer	0.00103	0.0082	CcSEcCtD
Erythromycin—CYP3A5—prostate gland—urinary bladder cancer	0.00101	0.0315	CbGeAlD
Erythromycin—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00101	0.008	CcSEcCtD
Erythromycin—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.001	0.00794	CcSEcCtD
Erythromycin—Hearing impaired—Cisplatin—urinary bladder cancer	0.000979	0.00777	CcSEcCtD
Erythromycin—Pain—Carboplatin—urinary bladder cancer	0.00097	0.00769	CcSEcCtD
Erythromycin—Abdominal pain—Valrubicin—urinary bladder cancer	0.000968	0.00768	CcSEcCtD
Erythromycin—Deafness—Thiotepa—urinary bladder cancer	0.000965	0.00765	CcSEcCtD
Erythromycin—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.000955	0.00757	CcSEcCtD
Erythromycin—Skin exfoliation—Cisplatin—urinary bladder cancer	0.00089	0.00706	CcSEcCtD
Erythromycin—ABCC1—urethra—urinary bladder cancer	0.000884	0.0274	CbGeAlD
Erythromycin—Discomfort—Mitomycin—urinary bladder cancer	0.000869	0.0069	CcSEcCtD
Erythromycin—Pruritus—Valrubicin—urinary bladder cancer	0.000866	0.00687	CcSEcCtD
Erythromycin—Confusional state—Mitomycin—urinary bladder cancer	0.00085	0.00675	CcSEcCtD
Erythromycin—Diarrhoea—Valrubicin—urinary bladder cancer	0.000838	0.00664	CcSEcCtD
Erythromycin—Eruption—Methotrexate—urinary bladder cancer	0.000832	0.0066	CcSEcCtD
Erythromycin—Hepatic function abnormal—Gemcitabine—urinary bladder cancer	0.000831	0.00659	CcSEcCtD
Erythromycin—Skin exfoliation—Etoposide—urinary bladder cancer	0.000815	0.00647	CcSEcCtD
Erythromycin—Deafness—Gemcitabine—urinary bladder cancer	0.000811	0.00644	CcSEcCtD
Erythromycin—Dizziness—Valrubicin—urinary bladder cancer	0.00081	0.00642	CcSEcCtD
Erythromycin—Anorexia—Mitomycin—urinary bladder cancer	0.000804	0.00638	CcSEcCtD
Erythromycin—Vomiting—Valrubicin—urinary bladder cancer	0.000778	0.00617	CcSEcCtD
Erythromycin—Eruption—Epirubicin—urinary bladder cancer	0.000778	0.00617	CcSEcCtD
Erythromycin—Rash—Valrubicin—urinary bladder cancer	0.000772	0.00612	CcSEcCtD
Erythromycin—Deafness—Cisplatin—urinary bladder cancer	0.000756	0.006	CcSEcCtD
Erythromycin—Burning sensation—Methotrexate—urinary bladder cancer	0.000736	0.00584	CcSEcCtD
Erythromycin—Decreased appetite—Mitomycin—urinary bladder cancer	0.000733	0.00582	CcSEcCtD
Erythromycin—Nausea—Valrubicin—urinary bladder cancer	0.000727	0.00577	CcSEcCtD
Erythromycin—Pain—Mitomycin—urinary bladder cancer	0.000721	0.00572	CcSEcCtD
Erythromycin—Eruption—Doxorubicin—urinary bladder cancer	0.00072	0.00571	CcSEcCtD
Erythromycin—CYP1A2—renal system—urinary bladder cancer	0.000717	0.0223	CbGeAlD
Erythromycin—Redness—Epirubicin—urinary bladder cancer	0.000709	0.00563	CcSEcCtD
Erythromycin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000695	0.00551	CcSEcCtD
Erythromycin—CYP3A5—renal system—urinary bladder cancer	0.000692	0.0215	CbGeAlD
Erythromycin—Burning sensation—Epirubicin—urinary bladder cancer	0.000689	0.00547	CcSEcCtD
Erythromycin—CYP2B6—renal system—urinary bladder cancer	0.000687	0.0213	CbGeAlD
Erythromycin—Irritability—Fluorouracil—urinary bladder cancer	0.000681	0.0054	CcSEcCtD
Erythromycin—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00067	0.00532	CcSEcCtD
Erythromycin—Hepatotoxicity—Methotrexate—urinary bladder cancer	0.000662	0.00525	CcSEcCtD
Erythromycin—Redness—Doxorubicin—urinary bladder cancer	0.000656	0.0052	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.000654	0.00519	CcSEcCtD
Erythromycin—ABCC1—vagina—urinary bladder cancer	0.000652	0.0202	CbGeAlD
Erythromycin—Jaundice—Thiotepa—urinary bladder cancer	0.000648	0.00514	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Epirubicin—urinary bladder cancer	0.000647	0.00513	CcSEcCtD
Erythromycin—Irritability—Cisplatin—urinary bladder cancer	0.000646	0.00512	CcSEcCtD
Erythromycin—Burning sensation—Doxorubicin—urinary bladder cancer	0.000637	0.00506	CcSEcCtD
Erythromycin—Ventricular arrhythmia—Doxorubicin—urinary bladder cancer	0.000598	0.00475	CcSEcCtD
Erythromycin—Hallucination—Thiotepa—urinary bladder cancer	0.000594	0.00471	CcSEcCtD
Erythromycin—Diarrhoea—Mitomycin—urinary bladder cancer	0.000577	0.00458	CcSEcCtD
Erythromycin—Pancreatitis—Cisplatin—urinary bladder cancer	0.000573	0.00455	CcSEcCtD
Erythromycin—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000561	0.00445	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.000558	0.00443	CcSEcCtD
Erythromycin—Dizziness—Mitomycin—urinary bladder cancer	0.000558	0.00442	CcSEcCtD
Erythromycin—Tinnitus—Thiotepa—urinary bladder cancer	0.000557	0.00442	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000555	0.0044	CcSEcCtD
Erythromycin—CYP2B6—female reproductive system—urinary bladder cancer	0.00055	0.0171	CbGeAlD
Erythromycin—ABCB1—prostate gland—urinary bladder cancer	0.000539	0.0167	CbGeAlD
Erythromycin—Vomiting—Mitomycin—urinary bladder cancer	0.000536	0.00425	CcSEcCtD
Erythromycin—Arrhythmia—Thiotepa—urinary bladder cancer	0.000533	0.00423	CcSEcCtD
Erythromycin—Rash—Mitomycin—urinary bladder cancer	0.000532	0.00422	CcSEcCtD
Erythromycin—Erythema—Thiotepa—urinary bladder cancer	0.00052	0.00412	CcSEcCtD
Erythromycin—CYP3A4—renal system—urinary bladder cancer	0.000519	0.0161	CbGeAlD
Erythromycin—Nausea—Mitomycin—urinary bladder cancer	0.000501	0.00397	CcSEcCtD
Erythromycin—CYP3A5—vagina—urinary bladder cancer	0.000501	0.0155	CbGeAlD
Erythromycin—CYP2B6—vagina—urinary bladder cancer	0.000498	0.0155	CbGeAlD
Erythromycin—Skin exfoliation—Methotrexate—urinary bladder cancer	0.000488	0.00387	CcSEcCtD
Erythromycin—Ventricular tachycardia—Epirubicin—urinary bladder cancer	0.000479	0.0038	CcSEcCtD
Erythromycin—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000475	0.00377	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000474	0.00376	CcSEcCtD
Erythromycin—Jaundice—Etoposide—urinary bladder cancer	0.000466	0.00369	CcSEcCtD
Erythromycin—Skin exfoliation—Epirubicin—urinary bladder cancer	0.000457	0.00363	CcSEcCtD
Erythromycin—ABCB1—seminal vesicle—urinary bladder cancer	0.000456	0.0142	CbGeAlD
Erythromycin—Convulsion—Thiotepa—urinary bladder cancer	0.00045	0.00357	CcSEcCtD
Erythromycin—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000449	0.00356	CcSEcCtD
Erythromycin—Ventricular tachycardia—Doxorubicin—urinary bladder cancer	0.000443	0.00351	CcSEcCtD
Erythromycin—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000441	0.0035	CcSEcCtD
Erythromycin—Erythema—Gemcitabine—urinary bladder cancer	0.000437	0.00347	CcSEcCtD
Erythromycin—Tinnitus—Cisplatin—urinary bladder cancer	0.000436	0.00346	CcSEcCtD
Erythromycin—Erythema—Fluorouracil—urinary bladder cancer	0.00043	0.00341	CcSEcCtD
Erythromycin—Confusional state—Thiotepa—urinary bladder cancer	0.000428	0.00339	CcSEcCtD
Erythromycin—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.000423	0.00335	CcSEcCtD
Erythromycin—ABCC1—lymph node—urinary bladder cancer	0.000422	0.0131	CbGeAlD
Erythromycin—Arrhythmia—Cisplatin—urinary bladder cancer	0.000418	0.00332	CcSEcCtD
Erythromycin—CYP3A4—female reproductive system—urinary bladder cancer	0.000416	0.0129	CbGeAlD
Erythromycin—Erythema—Cisplatin—urinary bladder cancer	0.000407	0.00323	CcSEcCtD
Erythromycin—Erythema multiforme—Etoposide—urinary bladder cancer	0.000405	0.00322	CcSEcCtD
Erythromycin—Anorexia—Thiotepa—urinary bladder cancer	0.000404	0.00321	CcSEcCtD
Erythromycin—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.000398	0.00315	CcSEcCtD
Erythromycin—ABCB1—epithelium—urinary bladder cancer	0.000396	0.0123	CbGeAlD
Erythromycin—Convulsion—Fluorouracil—urinary bladder cancer	0.000372	0.00295	CcSEcCtD
Erythromycin—Chest pain—Gemcitabine—urinary bladder cancer	0.000372	0.00295	CcSEcCtD
Erythromycin—Decreased appetite—Thiotepa—urinary bladder cancer	0.000369	0.00292	CcSEcCtD
Erythromycin—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.000368	0.00292	CcSEcCtD
Erythromycin—Discomfort—Gemcitabine—urinary bladder cancer	0.000368	0.00292	CcSEcCtD
Erythromycin—ABCB1—renal system—urinary bladder cancer	0.000367	0.0114	CbGeAlD
Erythromycin—Chest pain—Fluorouracil—urinary bladder cancer	0.000366	0.0029	CcSEcCtD
Erythromycin—Dysgeusia—Etoposide—urinary bladder cancer	0.000366	0.0029	CcSEcCtD
Erythromycin—Pain—Thiotepa—urinary bladder cancer	0.000363	0.00288	CcSEcCtD
Erythromycin—Discomfort—Fluorouracil—urinary bladder cancer	0.000362	0.00287	CcSEcCtD
Erythromycin—ABCB1—urethra—urinary bladder cancer	0.000361	0.0112	CbGeAlD
Erythromycin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000357	0.00283	CcSEcCtD
Erythromycin—Irritability—Methotrexate—urinary bladder cancer	0.000354	0.00281	CcSEcCtD
Erythromycin—Confusional state—Fluorouracil—urinary bladder cancer	0.000354	0.00281	CcSEcCtD
Erythromycin—Convulsion—Cisplatin—urinary bladder cancer	0.000353	0.0028	CcSEcCtD
Erythromycin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000351	0.00278	CcSEcCtD
Erythromycin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00035	0.00277	CcSEcCtD
Erythromycin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000347	0.00275	CcSEcCtD
Erythromycin—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000343	0.00272	CcSEcCtD
Erythromycin—Discomfort—Cisplatin—urinary bladder cancer	0.000343	0.00272	CcSEcCtD
Erythromycin—Anorexia—Gemcitabine—urinary bladder cancer	0.00034	0.0027	CcSEcCtD
Erythromycin—Urticaria—Thiotepa—urinary bladder cancer	0.000337	0.00267	CcSEcCtD
Erythromycin—Vertigo—Etoposide—urinary bladder cancer	0.000335	0.00266	CcSEcCtD
Erythromycin—Abdominal pain—Thiotepa—urinary bladder cancer	0.000335	0.00266	CcSEcCtD
Erythromycin—Anorexia—Fluorouracil—urinary bladder cancer	0.000334	0.00265	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.000334	0.00265	CcSEcCtD
Erythromycin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000333	0.00264	CcSEcCtD
Erythromycin—Convulsion—Etoposide—urinary bladder cancer	0.000323	0.00257	CcSEcCtD
Erythromycin—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000321	0.00254	CcSEcCtD
Erythromycin—Chest pain—Etoposide—urinary bladder cancer	0.000318	0.00252	CcSEcCtD
Erythromycin—Anorexia—Cisplatin—urinary bladder cancer	0.000317	0.00251	CcSEcCtD
Erythromycin—Pancreatitis—Methotrexate—urinary bladder cancer	0.000315	0.0025	CcSEcCtD
Erythromycin—Discomfort—Etoposide—urinary bladder cancer	0.000314	0.00249	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.000313	0.00248	CcSEcCtD
Erythromycin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000312	0.00248	CcSEcCtD
Erythromycin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00031	0.00246	CcSEcCtD
Erythromycin—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000308	0.00244	CcSEcCtD
Erythromycin—Confusional state—Etoposide—urinary bladder cancer	0.000307	0.00244	CcSEcCtD
Erythromycin—Pain—Gemcitabine—urinary bladder cancer	0.000305	0.00242	CcSEcCtD
Erythromycin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000305	0.00242	CcSEcCtD
Erythromycin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000305	0.00242	CcSEcCtD
Erythromycin—Pruritus—Thiotepa—urinary bladder cancer	0.0003	0.00238	CcSEcCtD
Erythromycin—Pain—Fluorouracil—urinary bladder cancer	0.0003	0.00238	CcSEcCtD
Erythromycin—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000297	0.00235	CcSEcCtD
Erythromycin—Pancreatitis—Epirubicin—urinary bladder cancer	0.000294	0.00234	CcSEcCtD
Erythromycin—ABCB1—female reproductive system—urinary bladder cancer	0.000294	0.00913	CbGeAlD
Erythromycin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000294	0.00233	CcSEcCtD
Erythromycin—Anorexia—Etoposide—urinary bladder cancer	0.00029	0.0023	CcSEcCtD
Erythromycin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00029	0.0023	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00029	0.0023	CcSEcCtD
Erythromycin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000289	0.00229	CcSEcCtD
Erythromycin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000289	0.00229	CcSEcCtD
Erythromycin—Pain—Cisplatin—urinary bladder cancer	0.000284	0.00226	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000284	0.00225	CcSEcCtD
Erythromycin—Dizziness—Thiotepa—urinary bladder cancer	0.00028	0.00223	CcSEcCtD
Erythromycin—Urticaria—Fluorouracil—urinary bladder cancer	0.000279	0.00221	CcSEcCtD
Erythromycin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000274	0.00217	CcSEcCtD
Erythromycin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000272	0.00216	CcSEcCtD
Erythromycin—Vomiting—Thiotepa—urinary bladder cancer	0.00027	0.00214	CcSEcCtD
Erythromycin—Rash—Thiotepa—urinary bladder cancer	0.000267	0.00212	CcSEcCtD
Erythromycin—ABCB1—vagina—urinary bladder cancer	0.000266	0.00826	CbGeAlD
Erythromycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000265	0.00211	CcSEcCtD
Erythromycin—Decreased appetite—Etoposide—urinary bladder cancer	0.000265	0.0021	CcSEcCtD
Erythromycin—Jaundice—Epirubicin—urinary bladder cancer	0.000261	0.00207	CcSEcCtD
Erythromycin—Pain—Etoposide—urinary bladder cancer	0.000261	0.00207	CcSEcCtD
Erythromycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000258	0.00205	CcSEcCtD
Erythromycin—Hepatitis—Methotrexate—urinary bladder cancer	0.000257	0.00204	CcSEcCtD
Erythromycin—Pruritus—Gemcitabine—urinary bladder cancer	0.000252	0.002	CcSEcCtD
Erythromycin—Nausea—Thiotepa—urinary bladder cancer	0.000252	0.002	CcSEcCtD
Erythromycin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000251	0.00199	CcSEcCtD
Erythromycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000249	0.00198	CcSEcCtD
Erythromycin—Pruritus—Fluorouracil—urinary bladder cancer	0.000248	0.00197	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000246	0.00195	CcSEcCtD
Erythromycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000245	0.00194	CcSEcCtD
Erythromycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000244	0.00194	CcSEcCtD
Erythromycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000243	0.00193	CcSEcCtD
Erythromycin—Urticaria—Etoposide—urinary bladder cancer	0.000242	0.00192	CcSEcCtD
Erythromycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000241	0.00192	CcSEcCtD
Erythromycin—Abdominal pain—Etoposide—urinary bladder cancer	0.000241	0.00191	CcSEcCtD
Erythromycin—Hepatitis—Epirubicin—urinary bladder cancer	0.00024	0.00191	CcSEcCtD
Erythromycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00024	0.0019	CcSEcCtD
Erythromycin—Tinnitus—Methotrexate—urinary bladder cancer	0.000239	0.0019	CcSEcCtD
Erythromycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000232	0.00184	CcSEcCtD
Erythromycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000228	0.00181	CcSEcCtD
Erythromycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000227	0.0018	CcSEcCtD
Erythromycin—Vomiting—Gemcitabine—urinary bladder cancer	0.000227	0.0018	CcSEcCtD
Erythromycin—Rash—Gemcitabine—urinary bladder cancer	0.000225	0.00178	CcSEcCtD
Erythromycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000224	0.00178	CcSEcCtD
Erythromycin—Tinnitus—Epirubicin—urinary bladder cancer	0.000224	0.00178	CcSEcCtD
Erythromycin—Erythema—Methotrexate—urinary bladder cancer	0.000224	0.00177	CcSEcCtD
Erythromycin—Vomiting—Fluorouracil—urinary bladder cancer	0.000223	0.00177	CcSEcCtD
Erythromycin—Hepatitis—Doxorubicin—urinary bladder cancer	0.000222	0.00176	CcSEcCtD
Erythromycin—Rash—Fluorouracil—urinary bladder cancer	0.000221	0.00175	CcSEcCtD
Erythromycin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000219	0.00174	CcSEcCtD
Erythromycin—Pruritus—Etoposide—urinary bladder cancer	0.000216	0.00171	CcSEcCtD
Erythromycin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000215	0.0017	CcSEcCtD
Erythromycin—Nausea—Gemcitabine—urinary bladder cancer	0.000212	0.00168	CcSEcCtD
Erythromycin—Vomiting—Cisplatin—urinary bladder cancer	0.000211	0.00168	CcSEcCtD
Erythromycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00021	0.00167	CcSEcCtD
Erythromycin—Rash—Cisplatin—urinary bladder cancer	0.00021	0.00166	CcSEcCtD
Erythromycin—Erythema—Epirubicin—urinary bladder cancer	0.000209	0.00166	CcSEcCtD
Erythromycin—Diarrhoea—Etoposide—urinary bladder cancer	0.000208	0.00165	CcSEcCtD
Erythromycin—Nausea—Fluorouracil—urinary bladder cancer	0.000208	0.00165	CcSEcCtD
Erythromycin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000207	0.00165	CcSEcCtD
Erythromycin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000205	0.00163	CcSEcCtD
Erythromycin—Dizziness—Etoposide—urinary bladder cancer	0.000201	0.0016	CcSEcCtD
Erythromycin—Vertigo—Methotrexate—urinary bladder cancer	0.000201	0.00159	CcSEcCtD
Erythromycin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000199	0.00158	CcSEcCtD
Erythromycin—Nausea—Cisplatin—urinary bladder cancer	0.000198	0.00157	CcSEcCtD
Erythromycin—Convulsion—Methotrexate—urinary bladder cancer	0.000194	0.00154	CcSEcCtD
Erythromycin—Vomiting—Etoposide—urinary bladder cancer	0.000194	0.00154	CcSEcCtD
Erythromycin—Erythema—Doxorubicin—urinary bladder cancer	0.000194	0.00154	CcSEcCtD
Erythromycin—Rash—Etoposide—urinary bladder cancer	0.000192	0.00152	CcSEcCtD
Erythromycin—Chest pain—Methotrexate—urinary bladder cancer	0.00019	0.00151	CcSEcCtD
Erythromycin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00019	0.0015	CcSEcCtD
Erythromycin—Discomfort—Methotrexate—urinary bladder cancer	0.000188	0.00149	CcSEcCtD
Erythromycin—Vertigo—Epirubicin—urinary bladder cancer	0.000188	0.00149	CcSEcCtD
Erythromycin—Palpitations—Epirubicin—urinary bladder cancer	0.000185	0.00147	CcSEcCtD
Erythromycin—Confusional state—Methotrexate—urinary bladder cancer	0.000184	0.00146	CcSEcCtD
Erythromycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000182	0.00145	CcSEcCtD
Erythromycin—Convulsion—Epirubicin—urinary bladder cancer	0.000181	0.00144	CcSEcCtD
Erythromycin—Nausea—Etoposide—urinary bladder cancer	0.000181	0.00144	CcSEcCtD
Erythromycin—Chest pain—Epirubicin—urinary bladder cancer	0.000178	0.00141	CcSEcCtD
Erythromycin—Discomfort—Epirubicin—urinary bladder cancer	0.000176	0.0014	CcSEcCtD
Erythromycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000174	0.00138	CcSEcCtD
Erythromycin—Anorexia—Methotrexate—urinary bladder cancer	0.000174	0.00138	CcSEcCtD
Erythromycin—Confusional state—Epirubicin—urinary bladder cancer	0.000172	0.00137	CcSEcCtD
Erythromycin—ABCB1—lymph node—urinary bladder cancer	0.000172	0.00534	CbGeAlD
Erythromycin—Palpitations—Doxorubicin—urinary bladder cancer	0.000171	0.00136	CcSEcCtD
Erythromycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000171	0.00135	CcSEcCtD
Erythromycin—Convulsion—Doxorubicin—urinary bladder cancer	0.000168	0.00133	CcSEcCtD
Erythromycin—Chest pain—Doxorubicin—urinary bladder cancer	0.000165	0.00131	CcSEcCtD
Erythromycin—Discomfort—Doxorubicin—urinary bladder cancer	0.000163	0.00129	CcSEcCtD
Erythromycin—Anorexia—Epirubicin—urinary bladder cancer	0.000163	0.00129	CcSEcCtD
Erythromycin—Confusional state—Doxorubicin—urinary bladder cancer	0.000159	0.00126	CcSEcCtD
Erythromycin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000159	0.00126	CcSEcCtD
Erythromycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000158	0.00125	CcSEcCtD
Erythromycin—Pain—Methotrexate—urinary bladder cancer	0.000156	0.00124	CcSEcCtD
Erythromycin—Anorexia—Doxorubicin—urinary bladder cancer	0.000151	0.00119	CcSEcCtD
Erythromycin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00015	0.00119	CcSEcCtD
Erythromycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000149	0.00118	CcSEcCtD
Erythromycin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000148	0.00118	CcSEcCtD
Erythromycin—Pain—Epirubicin—urinary bladder cancer	0.000146	0.00116	CcSEcCtD
Erythromycin—Urticaria—Methotrexate—urinary bladder cancer	0.000145	0.00115	CcSEcCtD
Erythromycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000144	0.00114	CcSEcCtD
Erythromycin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000141	0.00112	CcSEcCtD
Erythromycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00014	0.00111	CcSEcCtD
Erythromycin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000137	0.00109	CcSEcCtD
Erythromycin—Urticaria—Epirubicin—urinary bladder cancer	0.000136	0.00108	CcSEcCtD
Erythromycin—Pain—Doxorubicin—urinary bladder cancer	0.000135	0.00107	CcSEcCtD
Erythromycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000135	0.00107	CcSEcCtD
Erythromycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000134	0.00107	CcSEcCtD
Erythromycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00013	0.00103	CcSEcCtD
Erythromycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000129	0.00103	CcSEcCtD
Erythromycin—Pruritus—Methotrexate—urinary bladder cancer	0.000129	0.00102	CcSEcCtD
Erythromycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000126	0.000998	CcSEcCtD
Erythromycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000126	0.000996	CcSEcCtD
Erythromycin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000125	0.000991	CcSEcCtD
Erythromycin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000125	0.000991	CcSEcCtD
Erythromycin—Pruritus—Epirubicin—urinary bladder cancer	0.000121	0.000959	CcSEcCtD
Erythromycin—Dizziness—Methotrexate—urinary bladder cancer	0.000121	0.000957	CcSEcCtD
Erythromycin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000117	0.000927	CcSEcCtD
Erythromycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000116	0.000924	CcSEcCtD
Erythromycin—Vomiting—Methotrexate—urinary bladder cancer	0.000116	0.00092	CcSEcCtD
Erythromycin—Rash—Methotrexate—urinary bladder cancer	0.000115	0.000913	CcSEcCtD
Erythromycin—Dizziness—Epirubicin—urinary bladder cancer	0.000113	0.000896	CcSEcCtD
Erythromycin—Pruritus—Doxorubicin—urinary bladder cancer	0.000112	0.000887	CcSEcCtD
Erythromycin—Vomiting—Epirubicin—urinary bladder cancer	0.000109	0.000861	CcSEcCtD
Erythromycin—Nausea—Methotrexate—urinary bladder cancer	0.000108	0.00086	CcSEcCtD
Erythromycin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000108	0.000858	CcSEcCtD
Erythromycin—Rash—Epirubicin—urinary bladder cancer	0.000108	0.000854	CcSEcCtD
Erythromycin—Dizziness—Doxorubicin—urinary bladder cancer	0.000104	0.000829	CcSEcCtD
Erythromycin—Nausea—Epirubicin—urinary bladder cancer	0.000101	0.000805	CcSEcCtD
Erythromycin—Vomiting—Doxorubicin—urinary bladder cancer	0.0001	0.000797	CcSEcCtD
Erythromycin—Rash—Doxorubicin—urinary bladder cancer	9.96e-05	0.00079	CcSEcCtD
Erythromycin—Nausea—Doxorubicin—urinary bladder cancer	9.39e-05	0.000745	CcSEcCtD
Erythromycin—MLNR—Signaling Pathways—PTEN—urinary bladder cancer	4.52e-05	0.00056	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	4.51e-05	0.000559	CbGpPWpGaD
Erythromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	4.33e-05	0.000537	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EP300—urinary bladder cancer	4.31e-05	0.000534	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.29e-05	0.000532	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NAT2—urinary bladder cancer	4.29e-05	0.000532	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.27e-05	0.00053	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.26e-05	0.000528	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—SRC—urinary bladder cancer	4.19e-05	0.000519	CbGpPWpGaD
Erythromycin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.18e-05	0.000518	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	4.16e-05	0.000515	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TYMP—urinary bladder cancer	4.14e-05	0.000513	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	4.11e-05	0.00051	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ENO2—urinary bladder cancer	4.09e-05	0.000507	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	4.06e-05	0.000504	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.95e-05	0.00049	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	3.93e-05	0.000487	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	3.93e-05	0.000487	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.9e-05	0.000483	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RBX1—urinary bladder cancer	3.88e-05	0.000481	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	3.84e-05	0.000476	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	3.83e-05	0.000474	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	3.81e-05	0.000472	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	3.81e-05	0.000472	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.79e-05	0.00047	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—MYC—urinary bladder cancer	3.75e-05	0.000465	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NAT2—urinary bladder cancer	3.74e-05	0.000464	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	3.74e-05	0.000464	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.73e-05	0.000462	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.72e-05	0.000462	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.72e-05	0.000462	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—RRM2—urinary bladder cancer	3.7e-05	0.000459	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	3.69e-05	0.000458	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.68e-05	0.000457	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—EGFR—urinary bladder cancer	3.67e-05	0.000455	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.64e-05	0.000451	CbGpPWpGaD
Erythromycin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.63e-05	0.00045	CbGpPWpGaD
Erythromycin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.58e-05	0.000444	CbGpPWpGaD
Erythromycin—ABCC1—Disease—JAG1—urinary bladder cancer	3.47e-05	0.000431	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—KRAS—urinary bladder cancer	3.47e-05	0.00043	CbGpPWpGaD
Erythromycin—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.46e-05	0.000429	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—HPGDS—urinary bladder cancer	3.43e-05	0.000425	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ENO2—urinary bladder cancer	3.43e-05	0.000425	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.41e-05	0.000423	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.41e-05	0.000422	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTT1—urinary bladder cancer	3.32e-05	0.000412	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.27e-05	0.000406	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—RRM2—urinary bladder cancer	3.23e-05	0.0004	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.16e-05	0.000392	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	3.14e-05	0.000389	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.12e-05	0.000387	CbGpPWpGaD
Erythromycin—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.11e-05	0.000386	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—TP53—urinary bladder cancer	3.08e-05	0.000382	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	3.07e-05	0.000381	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.07e-05	0.00038	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMP—urinary bladder cancer	3.06e-05	0.000379	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.05e-05	0.000379	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	2.99e-05	0.000371	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ENO2—urinary bladder cancer	2.99e-05	0.000371	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.99e-05	0.000371	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.98e-05	0.000369	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.97e-05	0.000368	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.97e-05	0.000368	CbGpPWpGaD
Erythromycin—MLNR—Signaling Pathways—HRAS—urinary bladder cancer	2.95e-05	0.000366	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.92e-05	0.000362	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.9e-05	0.00036	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.9e-05	0.000359	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.82e-05	0.00035	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	2.77e-05	0.000343	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NQO1—urinary bladder cancer	2.76e-05	0.000343	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.76e-05	0.000342	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2.72e-05	0.000337	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.7e-05	0.000335	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.68e-05	0.000332	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.67e-05	0.000331	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.66e-05	0.00033	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.6e-05	0.000322	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	2.56e-05	0.000318	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.54e-05	0.000315	CbGpPWpGaD
Erythromycin—ABCC1—Disease—NCOR1—urinary bladder cancer	2.53e-05	0.000314	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.48e-05	0.000307	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.47e-05	0.000306	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	2.45e-05	0.000303	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.42e-05	0.0003	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	2.41e-05	0.000299	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	2.39e-05	0.000296	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	2.38e-05	0.000295	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERCC2—urinary bladder cancer	2.38e-05	0.000295	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	2.35e-05	0.000292	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	2.35e-05	0.000292	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.34e-05	0.00029	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	2.33e-05	0.000289	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	2.31e-05	0.000287	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTP1—urinary bladder cancer	2.3e-05	0.000286	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.29e-05	0.000284	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.29e-05	0.000284	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.26e-05	0.00028	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	2.25e-05	0.000279	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	2.25e-05	0.000279	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MTHFR—urinary bladder cancer	2.23e-05	0.000277	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.23e-05	0.000276	CbGpPWpGaD
Erythromycin—ABCC1—Disease—TERT—urinary bladder cancer	2.23e-05	0.000276	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.21e-05	0.000274	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	2.21e-05	0.000274	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	2.21e-05	0.000274	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	2.21e-05	0.000274	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.17e-05	0.000268	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	2.16e-05	0.000268	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	2.16e-05	0.000268	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	2.14e-05	0.000266	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—TYMS—urinary bladder cancer	2.14e-05	0.000266	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GSTM1—urinary bladder cancer	2.12e-05	0.000263	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—NCOR1—urinary bladder cancer	2.12e-05	0.000263	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.1e-05	0.00026	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.1e-05	0.00026	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	2.08e-05	0.000258	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.06e-05	0.000256	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.05e-05	0.000254	CbGpPWpGaD
Erythromycin—ABCC1—Disease—FGFR3—urinary bladder cancer	2.05e-05	0.000254	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.04e-05	0.000253	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—GPX1—urinary bladder cancer	2.03e-05	0.000251	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	2.01e-05	0.000249	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.99e-05	0.000247	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.89e-05	0.000234	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.87e-05	0.000232	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.87e-05	0.000232	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.85e-05	0.000229	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.85e-05	0.000229	CbGpPWpGaD
Erythromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.82e-05	0.000225	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.81e-05	0.000224	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.8e-05	0.000223	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.78e-05	0.000221	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.78e-05	0.000221	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.77e-05	0.000219	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.76e-05	0.000218	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.74e-05	0.000216	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CREBBP—urinary bladder cancer	1.74e-05	0.000216	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.74e-05	0.000216	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.74e-05	0.000215	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.73e-05	0.000214	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.69e-05	0.000209	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.63e-05	0.000202	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.62e-05	0.000201	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.58e-05	0.000196	CbGpPWpGaD
Erythromycin—ABCC1—Disease—RHOA—urinary bladder cancer	1.57e-05	0.000195	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PPARG—urinary bladder cancer	1.52e-05	0.000188	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	1.49e-05	0.000184	CbGpPWpGaD
Erythromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.48e-05	0.000184	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—CREBBP—urinary bladder cancer	1.46e-05	0.000181	CbGpPWpGaD
Erythromycin—ABCC1—Disease—ERBB2—urinary bladder cancer	1.46e-05	0.000181	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.00018	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTGS2—urinary bladder cancer	1.43e-05	0.000177	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.41e-05	0.000174	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.39e-05	0.000172	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	1.38e-05	0.000171	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	1.37e-05	0.000169	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	1.37e-05	0.000169	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.35e-05	0.000167	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	0.000166	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	0.000166	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.33e-05	0.000164	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.32e-05	0.000164	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.31e-05	0.000163	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	1.31e-05	0.000162	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	0.000161	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.3e-05	0.000161	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.29e-05	0.00016	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.28e-05	0.000159	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000159	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	0.000158	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	0.000157	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.26e-05	0.000156	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	0.000156	CbGpPWpGaD
Erythromycin—ABCC1—Disease—CDKN1A—urinary bladder cancer	1.25e-05	0.000154	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.24e-05	0.000154	CbGpPWpGaD
Erythromycin—ABCC1—Disease—PTEN—urinary bladder cancer	1.24e-05	0.000154	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.21e-05	0.00015	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTGS2—urinary bladder cancer	1.19e-05	0.000148	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EP300—urinary bladder cancer	1.19e-05	0.000147	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	0.000146	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.16e-05	0.000143	CbGpPWpGaD
Erythromycin—ABCC1—Disease—SRC—urinary bladder cancer	1.15e-05	0.000143	CbGpPWpGaD
Erythromycin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.1e-05	0.000137	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.1e-05	0.000136	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.08e-05	0.000135	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.05e-05	0.00013	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	0.000129	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.04e-05	0.000129	CbGpPWpGaD
Erythromycin—ABCC1—Disease—MYC—urinary bladder cancer	1.03e-05	0.000128	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.02e-05	0.000126	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.02e-05	0.000126	CbGpPWpGaD
Erythromycin—ABCC1—Disease—EGFR—urinary bladder cancer	1.01e-05	0.000125	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.01e-05	0.000125	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.01e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1e-05	0.000125	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1e-05	0.000125	CbGpPWpGaD
Erythromycin—ABCC1—Metabolism—EP300—urinary bladder cancer	9.93e-06	0.000123	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	9.79e-06	0.000121	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.75e-06	0.000121	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.65e-06	0.00012	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.57e-06	0.000119	CbGpPWpGaD
Erythromycin—ABCC1—Disease—KRAS—urinary bladder cancer	9.55e-06	0.000118	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.47e-06	0.000117	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	9.4e-06	0.000117	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	9.19e-06	0.000114	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	9.08e-06	0.000113	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.9e-06	0.00011	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.88e-06	0.00011	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	8.75e-06	0.000109	CbGpPWpGaD
Erythromycin—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.66e-06	0.000107	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.47e-06	0.000105	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	8.14e-06	0.000101	CbGpPWpGaD
Erythromycin—ABCC1—Disease—HRAS—urinary bladder cancer	8.11e-06	0.000101	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	8.1e-06	0.0001	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	8.04e-06	9.97e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	8.04e-06	9.97e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	7.7e-06	9.55e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	7.7e-06	9.55e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	7.56e-06	9.38e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.53e-06	9.33e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.22e-06	8.95e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	7.11e-06	8.81e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.94e-06	8.6e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.75e-06	8.37e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	6.72e-06	8.33e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.56e-06	8.14e-05	CbGpPWpGaD
Erythromycin—CYP2B6—Metabolism—EP300—urinary bladder cancer	6.41e-06	7.94e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.28e-06	7.79e-05	CbGpPWpGaD
Erythromycin—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.26e-06	7.76e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.21e-06	7.7e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.21e-06	7.7e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.94e-06	7.37e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.84e-06	7.24e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.76e-06	7.15e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.68e-06	7.04e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.54e-06	6.87e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.49e-06	6.8e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.95e-06	6.14e-05	CbGpPWpGaD
Erythromycin—ABCB1—Metabolism—EP300—urinary bladder cancer	4.72e-06	5.86e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.53e-06	5.62e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.45e-06	5.52e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.27e-06	5.3e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.95e-06	4.9e-05	CbGpPWpGaD
Erythromycin—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.77e-06	4.68e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.5e-06	4.34e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.05e-06	3.78e-05	CbGpPWpGaD
Erythromycin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.91e-06	3.61e-05	CbGpPWpGaD
